CLO & Secretary · LIGAND PHARMACEUTICALS INC · Common Stock
Side
SELL
Value
$111K
Shares
385
Price
$287.53
Executed
Sep 3, 2026
Disclosed
Sep 8, 2026
Disclosure timeline5 days from execution to publication · legal deadline 2 business days
Sep 3 executedSep 8, 2026 disclosed
LGND · daily
Yahoo Finance chart API
▲Execution▼Disclosure●Material company filing●Other disclosed buy●Other disclosed sellUnofficial public endpoint; daily OHLCV, split-adjusted. Replace with a licensed feed for production.
Disclosed 3 business days after execution (deadline: 2)
Historical behavior+1 / 15
Routine: 33 prior trades recorded in this security
Frequency & clustering+5 / 15
1 other actor traded the same direction within 14 days
Market events0 / 10
No material company filing within 60 days after the trade
Pre-arranged plan-10
Executed under a Rule 10b5-1 trading plan
The Insider Score measures how far a disclosure deviates from normal filing patterns. A high score is a prompt for research, not evidence of illegal insider trading.
Reardon Andrew filed this Form 4 reporting a open-market sale of LGND on Sep 3, 2026. It became public on Sep 8, 2026. The filing establishes the reported transaction and the filer's stated role. It does not establish why the trade was made or what the filer knew.
Extraction
Method
Form 4 XML
Confidence
1.00
CLO & Secretary
Reardon Andrewcik:0001950232
Issuer
LIGAND PHARMACEUTICALS INCcik:0000886163
Revision history · 0
No field has changed since this record was first ingested.
